Ameritas Investment Partners’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$111K Hold
11,180
﹤0.01% 1632
2025
Q4
$94.6K Sell
11,180
-1,550
-12% -$11.1K ﹤0.01% 1742
2025
Q3
$66.5K Hold
12,730
﹤0.01% 1935
2025
Q2
$44K Hold
12,730
﹤0.01% 2266
2025
Q1
$33.4K Hold
12,730
﹤0.01% 2326
2024
Q4
$52.4K Buy
12,730
+3,760
+42% +$20.5K ﹤0.01% 2149
2024
Q3
$63.5K Hold
8,970
﹤0.01% 2056
2024
Q2
$58.5K Hold
8,970
﹤0.01% 2057
2024
Q1
$74.5K Hold
8,970
﹤0.01% 1915
2023
Q4
$98.8K Hold
8,970
﹤0.01% 1741
2023
Q3
$75.4K Buy
8,970
+2,159
+32% +$23.2K ﹤0.01% 1847
2023
Q2
$85.5K Hold
6,811
﹤0.01% 1701
2023
Q1
$112K Hold
6,811
﹤0.01% 1460
2022
Q4
$142K Buy
6,811
+1,013
+17% +$19.4K 0.01% 1357
2022
Q3
$129K Hold
5,798
0.01% 1317
2022
Q2
$97K Buy
5,798
+390
+7% +$8.36K ﹤0.01% 1534
2022
Q1
$162K Hold
5,408
0.01% 1317
2021
Q4
$166K Buy
5,408
+818
+18% +$25.9K 0.01% 1346
2021
Q3
$145K Hold
4,590
0.01% 1454
2021
Q2
$168K Buy
4,590
+860
+23% +$28.3K 0.01% 1379
2021
Q1
$129K Buy
3,730
+987
+36% +$42.8K ﹤0.01% 1503
2020
Q4
$114K Hold
2,743
0.01% 1506
2020
Q3
$117K Buy
+2,743
New +$105K 0.01% 1340

Other funds holding RLAY